Business

CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand

CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand.

articleCardiac Biotech Solutions Inc.March 16, 20215/company/cb-scientific-inc/news/cb-scientific-inc-cbsc-distributor-mango-wellness-comes-to-an-agreement-to-provide-services-to-three-major-hospital-chains-in-thailand
CB Scientific, Inc. (CBSC) Distributor Mango Wellness Comes to an Agreement to Provide Services to Three Major Hospital Chains in Thailand

About this update from Cardiac Biotech Solutions Inc.

[{"type":"text","content":"Successful introductory product trials result in an agreement by three major hospital chains to use the my-Cam deviceESCONDIDO, CA / ACCESSWIRE / March 16, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, announces today the anticipated addition of three major hospital chains to use Remote Cardiac Monitoring Services in Thailand using the proprietary my-Cam device and associated cloud-based software portal through their exclusive authorized distributor Mango Wellness Co., Ltd. (MWC).Mango Wellness Co., Ltd., due to the successful on-site trial evaluations of our innovative my- Cam monitor and my-Cardia software portal in two regions of Thailand, has come to a formal agreement to provide Remote Cardiac Monitoring Services to three major hospital chains. Ramkhamhaeng Hospital (one of the five largest private hospital groups in Thailand consisting of 40 hospitals), Bangkok Hospital Nakon Ratchasima (one of the largest hospitals in NE Thailand), and Bangpakok9 Hospital have all agreed to offer my-Cam services through MWC to their physicians and associated patients beginning in April 2021. Mango Wellness Co., Ltd. and its subsidiary My Cardia Thailand, in further efforts to expand its product offering, continue trials of the my-Cam device, which today consists of 102 cardiologists in 42 hospitals totaling more than 1700 ambulatory remote cardiac event monitoring tests to date since the beginning of the year. As apart of these trials, MWC is also in negotiations with N Health Services, a purchasing subsidiary of Bangkok Dusit Medical Services (BDMS - one of the most prestigious hospital networks in the Asia-Pacific region), to secure a joint marketing partnership to promote MWC's Remote Cardiac Monitoring Services to the 48 hospitals in the BDMS network in Thailand."Mango Wellness is very pleased with how well the my-Cam device has performed and has been received throughout this introductory trial period in our country. With a diagnostic success rate of 85%, including endorsements from several electrophysiologists and cardiologists as part of these successful trials, I remain extremely optimistic about the tremendous potential of the Remote Cardiac Monitoring market in Thailand. Duri...

More updates from Cardiac Biotech Solutions Inc.